Evidence map›Paper›PMID 40055319›Full record

ArticleNature communications2025

Continuous map of early hematopoietic stem cell differentiation across human lifetime.

Hana Komic, Tessa Schmachtel, Catia Simoes, Marius Külp, Weijia Yu, Adrien Jolly, Malin S Nilsson, Carmen Gonzalez, Felipe Prosper, Halvard Bonig and 3 more

Abstract read
In one paragraph

Article in Nature communications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. FACS-Based Assessment of Human Hematopoietic Stem and Progenitor Cells.International journal of molecular sciences · 2025
    Review
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Hana Komic *TIMM Laboratory at Sahlgrenska Center for Cancer Research, University of Gothenburg, Gothenburg, Sweden.ORCID http://orcid.org/0000-0001-5209-393X
Tessa Schmachtel *Department of Medicine 2, Hematology/Oncology, Goethe University Frankfurt, Frankfurt am Main, Germany.
Catia Simoes *Cancer Center Clínica Universidad de Navarra, Centro de Investigación Médica Aplicada (CIMA), IDISNA, CIBER-ONC number CB16/12/00369 and CB16/12/00489, Pamplona, Spain.
Marius Külp *Department of Medicine 2, Hematology/Oncology, Goethe University Frankfurt, Frankfurt am Main, Germany.ORCID http://orcid.org/0000-0002-6594-8412
Weijia YuDepartment of Medicine 2, Hematology/Oncology, Goethe University Frankfurt, Frankfurt am Main, Germany.ORCID http://orcid.org/0000-0001-8471-3048
Adrien JollyDepartment of Medicine 2, Hematology/Oncology, Goethe University Frankfurt, Frankfurt am Main, Germany.ORCID http://orcid.org/0000-0002-2609-5621
Malin S NilssonTIMM Laboratory at Sahlgrenska Center for Cancer Research, University of Gothenburg, Gothenburg, Sweden.ORCID http://orcid.org/0000-0002-0981-2617
Carmen GonzalezCancer Center Clínica Universidad de Navarra, Centro de Investigación Médica Aplicada (CIMA), IDISNA, CIBER-ONC number CB16/12/00369 and CB16/12/00489, Pamplona, Spain.ORCID http://orcid.org/0009-0001-3074-9229
Felipe ProsperCancer Center Clínica Universidad de Navarra, Centro de Investigación Médica Aplicada (CIMA), IDISNA, CIBER-ONC number CB16/12/00369 and CB16/12/00489, Pamplona, Spain.ORCID http://orcid.org/0000-0001-6115-8790
Halvard BonigInstitute for Transfusion Medicine and Immunohematology, Goethe University Frankfurt, Frankfurt am Main, Germany.
Bruno PaivaCancer Center Clínica Universidad de Navarra, Centro de Investigación Médica Aplicada (CIMA), IDISNA, CIBER-ONC number CB16/12/00369 and CB16/12/00489, Pamplona, Spain.ORCID http://orcid.org/0000-0003-1977-3815
Fredrik B ThorénTIMM Laboratory at Sahlgrenska Center for Cancer Research, University of Gothenburg, Gothenburg, Sweden.ORCID http://orcid.org/0000-0003-2167-7451
Michael A RiegerDepartment of Medicine 2, Hematology/Oncology, Goethe University Frankfurt, Frankfurt am Main, Germany. m.rieger@em.uni-frankfurt.de.ORCID http://orcid.org/0000-0002-4158-5872

Funding

Deutsche Forschungsgemeinschaft (German Research Foundation) RI 2462/10-1Deutsche Forschungsgemeinschaft (German Research Foundation) RI 2462/9-1Hessisches Ministerium für Wissenschaft und Kunst (Hessen State Ministry of Higher Education, Research and the Arts) III L 5 - 519/03/03.001 - [0015]José Carreras Leukämie-Stiftung (Deutsche José Carreras Leukämie-Stiftung) DJCLS 15R/2023
6 · The paper itself

Abstract

Uncovering early gene network changes of human hematopoietic stem cells (HSCs) leading to differentiation induction is of utmost importance for therapeutic manipulation. We employed single cell proteo-transcriptomic sequencing to FACS-enriched bone marrow hematopoietic stem and progenitor cells (HSPCs) from 15 healthy donors. Pseudotime analysis reveals four major differentiation trajectories, which remain consistent upon aging, with an early branching point into megakaryocyte-erythroid progenitors. However, young donors suggest a more productive differentiation from HSPCs to committed progenitors of all lineages. tradeSeq analysis depicts continuous changes in gene expression of HSPC-related genes (DLK1, ADGRG6), and provides a roadmap of gene expression at the earliest branching points. We identify CD273/PD-L2 to be highly expressed in a subfraction of immature multipotent HSPCs with enhanced quiescence. Functional experiments confirm the immune-modulatory function of CD273/PD-L2 on HSPCs in regulating T-cell activation and cytokine release. Here, we present a molecular map of early HSPC differentiation across human life.

Indexed as

Cell DifferentiationHematopoietic Stem CellsAdultCell LineageFemaleGene Expression ProfilingHumansMaleMiddle AgedSingle-Cell AnalysisYoung Adult

Identifiers

PMID40055319
PMCPMC11889232

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.